These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30764500)

  • 1. Cord-Blood-Stem-Cell-Derived Conventional Dendritic Cells Specifically Originate from CD115-Expressing Precursors.
    Plantinga M; de Haar CG; Dünnebach E; van den Beemt DAMH; Bloemenkamp KWM; Mokry M; Boelens JJ; Nierkens S
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30764500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD14 Expressing Precursors Give Rise to Highly Functional Conventional Dendritic Cells for Use as Dendritic Cell Vaccine.
    Plantinga M; van den Beemt DAMH; Dünnebach E; Nierkens S
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell-derived myeloid and plasmacytoid DC-based vaccines are highly potent inducers of tumor-reactive T cell and NK cell responses
    Thordardottir S; Schaap N; Louer E; Kester MG; Falkenburg JH; Jansen J; Radstake TR; Hobo W; Dolstra H
    Oncoimmunology; 2017; 6(3):e1285991. PubMed ID: 28405517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple two-step culture system for the large-scale generation of mature and functional dendritic cells from umbilical cord blood CD34+ cells.
    Balan S; Kale VP; Limaye LS
    Transfusion; 2009 Oct; 49(10):2109-21. PubMed ID: 19497054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of dendritic cells from fresh and frozen cord blood CD34+ cells.
    Sato K; Nagayama H; Takahashi TA
    Cryobiology; 1998 Dec; 37(4):362-71. PubMed ID: 9917353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA-loaded dendritic cells for cancer vaccination.
    Brabants E; Heyns K; De Smet S; Devreker P; Ingels J; De Cabooter N; Debacker V; Dullaers M; VAN Meerbeeck JP; Vandekerckhove B; Vermaelen KY
    Cytotherapy; 2018 Sep; 20(9):1164-1181. PubMed ID: 30122654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma.
    Hinkel A; Tso CL; Gitlitz BJ; Neagos N; Schmid I; Paik SH; deKernion J; Figlin R; Belldegrun A
    J Immunother; 2000 Jan; 23(1):83-93. PubMed ID: 10687141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation.
    Encabo A; Solves P; Carbonell-Uberos F; Miñana MD
    Transfusion; 2007 Feb; 47(2):272-9. PubMed ID: 17302774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines in the generation and maturation of dendritic cells: recent advances.
    Zou GM; Tam YK
    Eur Cytokine Netw; 2002; 13(2):186-99. PubMed ID: 12101074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically modified dendritic cells in cancer therapy: implications for transfusion medicine.
    Foley R; Tozer R; Wan Y
    Transfus Med Rev; 2001 Oct; 15(4):292-304. PubMed ID: 11668436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of ex vivo expanded DCs derived from cord blood and mobilized adult peripheral blood plastic-adherent mononuclear cells: decreased alloreactivity of cord blood DCs.
    Bracho F; van de Ven C; Areman E; Hughes RM; Davenport V; Bradley MB; Cai JW; Cairo MS
    Cytotherapy; 2003; 5(5):349-61. PubMed ID: 14578097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fully closed and automated enrichment of primary blood dendritic cells for cancer immunotherapy.
    Schreibelt G; Duiveman-de Boer T; Pots JM; van Oorschot TGM; de Boer AJ; Scharenborg NM; van de Rakt MWMM; Bos K; de Goede AL; Petry K; Brüning M; Angerer C; Schöggl C; Dzionek A; de Vries IJM
    Methods Cell Biol; 2024; 183():33-50. PubMed ID: 38548417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Umbilical cord blood-derived dendritic cells loaded with BGC823 tumor antigens and DC-derived exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumor immunity in vitro and in vivo.
    Guan S; Li Q; Liu P; Xuan X; Du Y
    Cent Eur J Immunol; 2014; 39(2):142-51. PubMed ID: 26155115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation.
    de Haar C; Plantinga M; Blokland NJ; van Til NP; Flinsenberg TW; Van Tendeloo VF; Smits EL; Boon L; Spel L; Boes M; Boelens JJ; Nierkens S
    Oncoimmunology; 2015 Nov; 4(11):e1023973. PubMed ID: 26451309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costimulatory function of umbilical cord blood CD14+ and CD34+ derived dendritic cells.
    Dilioglou S; Cruse JM; Lewis RE
    Exp Mol Pathol; 2003 Aug; 75(1):18-33. PubMed ID: 12834622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.
    Zheng Z; Takahashi M; Narita M; Toba K; Liu A; Furukawa T; Koike T; Aizawa Y
    J Hematother Stem Cell Res; 2000 Aug; 9(4):453-64. PubMed ID: 10982243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses.
    Ueno H; Tcherepanova I; Reygrobellet O; Laughner E; Ventura C; Palucka AK; Banchereau J
    J Immunol Methods; 2004 Feb; 285(2):171-80. PubMed ID: 14980432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human dendritic cells engineered to express alpha tumor necrosis factor maintain cellular maturation and T-cell stimulation capacity.
    Ye Z; Chen Z; Sami A; El-Gayed A; Xiang J
    Cancer Biother Radiopharm; 2006 Dec; 21(6):613-22. PubMed ID: 17257077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated Good Manufacturing Practice-compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for cancer vaccines.
    Uslu U; Erdmann M; Wiesinger M; Schuler G; Schuler-Thurner B
    Cytotherapy; 2019 Nov; 21(11):1166-1178. PubMed ID: 31668486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.